Medicine guide
BUSCOPRESC COMPOSITUM
As listed in the register: BUSCOPRESC COMPOSITUM 2500 mg/20 mg SOLUCIÓN INYECTABLE
20mg escopolamina butilbromuro;2500mg metamizol · solución inyectable
- Prescription only
- Digestion, stomach, diabetes and nutrition
- Active substance
- Butilescopolamina bromuro + metamizol
- Made by
- Opella Healthcare Spain S.L.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupDigestion, stomach, diabetes and nutritionA03DB04
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Opella Healthcare Spain S.L. |
|---|---|
| Active substance | Butilescopolamina bromuro + metamizol |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 20mg escopolamina butilbromuro;2500mg metamizol |
| Form | solución inyectable |
| Classification | A03DB04 · Digestion, stomach, diabetes and nutrition |
| Route | vía intramuscular, vía intravenosa |
| Marketed | Yes, according to the register |
| Supply | The regulator reports a supply problem for this product. |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | BUSCOPRESC COMPOSITUM 2500 mg/20 mg SOLUCIÓN INYECTABLE |
| Nº Registro | 26791 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.